BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1152 related articles for article (PubMed ID: 4154047)

  • 21. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 22. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
    Monaco AP; Liegeois A; Wood ML; Clark AW
    Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenetic disparity and graft-versus-host reactions.
    Bach ML; Bach FH
    Semin Hematol; 1974 Jul; 11(3):291-303. PubMed ID: 4151845
    [No Abstract]   [Full Text] [Related]  

  • 24. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S; Rodt H
    Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against secondary syndrome by facilitating immune sera.
    Voisin JE; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1973 Feb; 124(1):75-85. PubMed ID: 4146716
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune competence of splenic lymphocytes following graft-vs-host disease in mouse allogeneic radiation chimeras.
    Urso P; Gengozian N
    J Immunol; 1977 Feb; 118(2):657-61. PubMed ID: 14214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The suppression of sheep rosette-forming cells and the inability of mouse bone marrow cells to reconstitute competence after infbction with the nematode Trichinella spiralis.
    Faubert GM; Tanner CE
    Immunology; 1974 Sep; 27(3):501-5. PubMed ID: 4607261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spleen colony-forming performance of bone marrow cells as a function of immune or nonimmune interactions induced by various H-2 disparities.
    Lengerová A; Matousek V; Zelený V
    Transplant Proc; 1973 Dec; 5(4):1389-91. PubMed ID: 4590622
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune response to soluble H-2Kd antigens.
    Götze D; Reisfeld RA
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(1):45-61. PubMed ID: 4283031
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
    Miller SC
    J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of total lymphoid irradiation (TLI) in bone marrow and organ transplantation.
    Strober S; Gottlieb M; Slavin S; Hoppe R; Grumet FC; Kaplan HS
    Transplant Proc; 1979 Dec; 11(4):1930-3. PubMed ID: 43614
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow transplantation. Influence of T lymphocytes on the process of differentiation and proliferation of bone marrow cells.
    Vitale B; Burek V; Plavljanić D
    Transplant Proc; 1977 Mar; 9(1):269-72. PubMed ID: 17193
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 35. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of bone marrow cells to reconstitute T cell immunity in graft-vs-host mice.
    Lang P; Miller MW; Shearer GM
    J Immunol; 1985 Apr; 134(4):2050-2. PubMed ID: 3882828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engraftment of allogeneic bone marrow cells: experimental investigations on the role of cell dose, graft-versus-host reactive T cells and pretransplant immunosuppression.
    Uharek L; Glass B; Gassmann W; Eckstein V; Steinmann J; Loeffler H; Mueller-Ruchholtz W
    Transplant Proc; 1992 Dec; 24(6):3023-5. PubMed ID: 1466042
    [No Abstract]   [Full Text] [Related]  

  • 38. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():301-5. PubMed ID: 4607384
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated immunity and aging.
    Stutman O
    Fed Proc; 1974 Sep; 33(9):2028-32. PubMed ID: 4153574
    [No Abstract]   [Full Text] [Related]  

  • 40. Human marrow transplantation--current status.
    Buckner CD; Clift RA; Fefer A; Neiman P; Storb R; Thomas ED
    Prog Hematol; 1973; 8():299-324. PubMed ID: 4150971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.